SCAI and SIR are coming together to explore the future of endovascular therapy for acute pulmonary embolism with insights from the PEERLESS trial, the first randomized comparison of catheter-based interventions for intermediate-risk PCI. This event offers expert panel discussion examining the possible implications of this data on clinical practice - as well as questions that are still unanswered - with the goal of helping you stay informed in this evolving field.

Additionally, this expert interdisciplinary panel will discuss other pivotal clinical trials on the horizon that could generate Level 1 evidence, aiming to support your practice with high standards of clinical research. The panel will also answer questions live during this event.

Don’t miss this opportunity to enhance your expertise and elevate patient care. Register now to secure your spot!